The global gastric cancer diagnostics market is gaining increasing importance as gastric cancer remains one of the leading causes of cancer-related mortality worldwide. Early and accurate diagnosis plays a critical role in improving patient outcomes, driving demand for advanced diagnostic technologies. Rising awareness about early cancer screening, growing prevalence of Helicobacter pylori infections, and increasing adoption of precision medicine approaches are significantly influencing market dynamics. Continuous technological advancements in molecular diagnostics, imaging systems, and biomarker-based testing are further strengthening the role of diagnostics across the gastric cancer care continuum, from screening and detection to prognosis and treatment monitoring.
Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=Srep_id=86864
Market Size and Growth
In 2024, the global gastric cancer diagnostics market was valued at approximately US$ 3.5 billion. The market is projected to nearly double in value, reaching around US$ 6.9 billion by 2035. This robust expansion reflects a compound annual growth rate (CAGR) of 6.4% from 2025 to 2035. Market growth is supported by rising cancer incidence rates, particularly among aging populations, as well as improvements in healthcare infrastructure across emerging economies. Additionally, increased investments in oncology research, favorable reimbursement policies for cancer diagnostics in developed markets, and the growing clinical utility of non-invasive diagnostic tests are contributing to sustained market expansion.
Market Segmentation
The gastric cancer diagnostics market is segmented based on test type, technology, end user, and application. By test type, the market includes imaging tests, biopsy and histopathology, molecular diagnostics, and blood-based biomarker tests. Molecular diagnostics and liquid biopsy technologies are witnessing strong growth due to their high sensitivity, specificity, and ability to support personalized treatment strategies. Based on end users, hospitals and diagnostic laboratories account for the largest share, driven by high patient inflow and access to advanced diagnostic equipment. Research institutes and specialty cancer centers are also emerging as important contributors, particularly in the development and validation of novel diagnostic assays.
Regional Analysis
Regionally, Asia Pacific dominates the gastric cancer diagnostics market due to the high prevalence of gastric cancer in countries such as China, Japan, and South Korea. Strong government-led screening programs and widespread adoption of endoscopic diagnostics support regional growth. North America represents a significant market, driven by advanced healthcare systems, early adoption of innovative diagnostic technologies, and strong presence of leading diagnostic companies. Europe follows closely, benefiting from rising cancer awareness and expanding molecular diagnostics capabilities. Meanwhile, Latin America and the Middle East Africa are expected to witness moderate growth as healthcare access improves and cancer screening initiatives expand.
Competitive Landscape
The global gastric cancer diagnostics market is highly competitive, with both multinational corporations and specialized biotechnology firms actively innovating to strengthen their market position. Key players include Abbott, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, MiRXES Pte Ltd., Endofotonics Pte Ltd., Hipro Biotechnology Co., Ltd., Fulgent Genetics, NeoGenomics Laboratories, Samsung Medison Co., Ltd., Natera, Inc., Randox Laboratories Ltd., GE HealthCare, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, and Promega Corporation. These companies focus on strategic collaborations, product launches, and technological advancements to expand their diagnostic portfolios and geographic reach.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
